"There is this mentality that hospice means the patient is going to die very soon, and that's really not true," said Maen Hussein, MD, physician director of finance at Florida Cancer Specialists.
"There is this mentality that hospice means the patient is going to die very soon, and that's really not true," said Maen Hussein, MD, physician director of finance at Florida Cancer Specialists.
Transcript:
Have you seen inprovements in the proposed Oncology Care First Model when it comes to accounting for high-cost drugs for some patients? Which proposed change do you believe is the most important?
I think it's still early to judge if the changes have an impact. I think one of the things that seemed to be promising that they had the risk assessment for each cancer so they have the risk stratification, That might help in the future to assess for each type of cancer, how much it will cost to treat those patients and that will help in the bundled payment in the future.
What will CMS's proposed change in the way Medicare Advantage pays for hospice mean for community oncology practices?
I think that hospice is being underutilized in caring for our patients. There is this mentality that hospice means that the patient is going to die very soon, that's really not true. There are more data showing that palliative care and hospice actually help improve the quality of life, and in some cases, even survivorship. I believe that the new changes will help and encourage the oncologists to bring up that topic sooner than later, and maybe help the patient accept that concept and change the culture to understand that being under hospice care, doesn't mean you're dying tomorrow. Actually, the indication for hospice, if the patient has survived, it's less than 6 months, and that actually can be extended. It doesn't mean that you're even dying within 6 months, but that's usually the period and if the patient lived to 6 months, you can even extend that. That will encourage the physicians to approach the patient sooner than later; talking about the option of hospice. I can see that culture change. I've been practicing here for almost 15 years now. It was much harder to talk about hospice before than now, especially when you explain to the patient that this is not the end you're not giving up. But it's a way to focus on your pain and uncomfort and still allow for some palliative therapies. A lot of hospice now are accepting, to pay for radiation therapy or even sometimes some forms of chemotherapy.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More